Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Melphalan”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00089401
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 8
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05893654
What this trial is testing

Melphalan Chemoreduction for Ocular Melanoma

Who this might be right for
Uveal Melanoma
Hospital das Clínicas de Ribeirão Preto 10
Testing effectiveness (Phase 2)Ended earlyNCT01746173
What this trial is testing

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

Who this might be right for
T-cell Non-Hodgkin Lymphoma
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Ended earlyNCT01393769
What this trial is testing

Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage

Who this might be right for
Retinoblastoma
Hospital Sant Joan de Deu 5
Testing effectiveness (Phase 2)UnknownNCT01255527
What this trial is testing

Evaluating the Efficacy and Safety of the Lower Dose of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation- KMM103 Study

Who this might be right for
Multiple Myeloma Patients Who Candidate for Autologous Peripheral Blood Stem Cell Transplantation
Yonsei University 53
Large-scale testing (Phase 3)Active Not RecruitingNCT03742297
What this trial is testing

Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years

Who this might be right for
Newly Diagnosed Multiple Myeloma
PETHEMA Foundation 462
Large-scale testing (Phase 3)Looking for participantsNCT06829472
What this trial is testing

Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan

Who this might be right for
ToxicitiesSurvivorship
Shanghai Jiao Tong University School of Medicine 120
Not applicableUnknownNCT05863845
What this trial is testing

Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 52
Testing effectiveness (Phase 2)Study completedNCT00948922
What this trial is testing

Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 124
Testing effectiveness (Phase 2)Ended earlyNCT01653418
What this trial is testing

Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06133556
What this trial is testing

Conditioning Regimen Containing Melphalan and Cladribine for Refractory / Relapsed AML

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 237
Early research (Phase 1)Study completedNCT00003081
What this trial is testing

Combination Chemotherapy, Peripheral Stem Cell Transplantation, and Radiation Therapy in Treating Patients With Ewing's Sarcoma, Peripheral Primitive Neuroectodermal Tumor, or Rhabdomyosarcoma

Who this might be right for
Sarcoma
Fred Hutchinson Cancer Center 16
Large-scale testing (Phase 3)Study completedNCT00004165
What this trial is testing

Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Northwestern University
Early research (Phase 1)Study completedNCT00030082
What this trial is testing

Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Liver CancerMetastatic Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00772811
What this trial is testing

Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma

Who this might be right for
Chronic Lymphocytic LeukemiaLymphomaMultiple Myeloma
Cooperative Study Group A for Hematology 38
Testing effectiveness (Phase 2)Study completedNCT01453101
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 54
Testing effectiveness (Phase 2)UnknownNCT01063439
What this trial is testing

BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)

Who this might be right for
Non Hodgkin's Lymphoma
Inje University 42
Testing effectiveness (Phase 2)UnknownNCT04904237
What this trial is testing

Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML.

Who this might be right for
Refractory Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine 23
Testing effectiveness (Phase 2)Study completedNCT04099901
What this trial is testing

Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial

Who this might be right for
Multiple Myeloma
Radboud University Medical Center 88
Testing effectiveness (Phase 2)Study completedNCT04682405
What this trial is testing

Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 51
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation